Hathaway Corporation Enters Into LOI With Korean Medical Device Manufacturer, U & I Bio-Tech, Inc.

SAINT PETERSBURG, FL--(Marketwire - February 04, 2008) - Hathaway Corporation (PINKSHEETS: HWYI), a company that focuses on acquiring, developing, and managing disruptive technologies in the telecommunications, medical devices, and software fields that change the way companies grow and service their businesses globally, announced that the Company has entered into a Letter of Intent for a joint venture with U&I Bio-Tech, Inc., a South Korea-based Medical Device Company, for BioHarp, a unique diagnostic medical device currently in development by U&I. BioHarp's revolutionary patented technology will provide physicians with the capability to diagnose a variety of ailments quickly, accurately, and in a totally safe and non-invasive manner.